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Marek’s disease virus (MDV) encodes an ubiquitin-speciﬁc protease (USP) within its UL36 gene. USP is
highly conserved among herpesviruses and was shown to be important for MDV replication and
pathogenesis in MDV’s natural host, the chicken. To further investigate the role of MDV USP, several
recombinant (r) MDVs were generated and their in vitro phenotypes were evaluated using plaque size
and growth kinetics assays. We discovered that the N-terminus of pUL36 is essential for MDV
replication and could not be complemented by ectopic expression of MDV USP. In addition, we
demonstrated that the region located between the conserved glutamine (Q85) and leucine (L106)
residues comprising the active site cysteine (C98) is also essential for MDV replication. Based on the
analyses of the rMDVs generated here, we concluded that MDV USP likely contributes to the structure
and/or stability of pUL36 and affects replication and oncogenesis of MDV beyond its enzymatic activity.
& 2013 Elsevier Inc. All rights reserved.Introduction
The ubiquitin (Ub)-proteasome pathway is a key regulator of
many physiological processes in eukaryotic cells (Komander et al.,
2009; Pickart and Eddins, 2004), including cell-cycle regulation,
stress response, DNA repair, immune responses, signal transduc-
tion, transcriptional regulation, endocytosis, and vesicle trafﬁck-
ing (Bolstad et al., 2011; Chau et al., 1989; Costa and Paulson,
2011; Glickman and Ciechanover, 2002). Post-translational mod-
iﬁcation and degradation of proteins via Ub-proteasome pathway
requires three components; ubiquitin-activating enzymes (E1),
ubiquitin-conjugating enzymes (E2), and ubiquitin ligases (E3)
that facilitate the conjugation of Ub to targeted proteins
(Glickman and Ciechanover, 2002). Furthermore, Ub can be
released from its covalent isopeptide bond from proteins by
deubiquitinases (DUBs), which prevents degradation of the pro-
tein by proteasomal or lysosomal pathways. DUBs can also affect
the cellular localization of proteins by Ub chain modiﬁcation
(Bucks et al., 2007; Chau et al., 1989), are both substrate- and Ub
chain-speciﬁc, and contribute to Ub homeostasis by Ub chain
recycling (Chau et al., 1989; Nijman et al., 2005). Five DUB classesll rights reserved.
ie, Freie Universita¨t Berlin,
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. Jarosinski),have been identiﬁed so far based on the characteristic of the
catalytic domain, with four classes being cysteine proteases and
one class of metalloproteases (Cardone et al., 2012; Chau et al.,
1989; Clinton et al., 2010). The Ub-speciﬁc cysteine proteases
(USPs) are the most numerous class, with more than 50 members
encoded in the human genome (Colleaux et al., 1986). Due to its
importance, the Ub-proteasome pathway is targeted by many
viruses, which express proteins that either tag cellular proteins
for degradation or encode their own Ub-proteasome pathway
components (Bolstad et al., 2011; Isaacson and Ploegh, 2009).
Marek’s disease is a serious illness of poultry worldwide that is
caused by Marek’s disease virus (MDV, Gallid herpesvirus type 2,
GaHV-2), a member of the Mardivirus genus within the Alphaher-
pesvirinae subfamily (Davison et al., 2009). Marek’s disease was
originally described by Jo´zsef Marek in 1907 as a sporadic chronic
polyneuritis (Osterrieder et al., 2006), but has evolved into a
deadly and highly transmissible disease that causes disseminated
visceral T cell lymphomas and neurological signs in infected
animals (Jarosinski et al., 2006; Michael et al., 2006; Osterrieder
et al., 2006). Marek’s disease is an excellent model for studying
herpesvirus pathogenesis and gene function in vivo, as the chicken
is the natural host of MDV (Osterrieder et al., 2006). Several MDV-
encoded genes related to oncogenesis have so far been identiﬁed,
such as the major oncogene meq that is directly involved in
transformation (Jones et al., 1992; Lupiani et al., 2004) and the
viral telomerase RNA that performs an auxiliary function in
cancer by stabilizing telomeres of transformed cells (Fragnet
Fig. 1. Comparison of the USP cysteine box of representative herpesviruses. Alignment of the N-terminal portion of representative herpesvirus USPs with their
conserved cysteine box regions shaded in light gray. The cysteines (C), glutamines (Q) and leucines (L) are highly conserved in all known herpesvirus analyzed. Numbers
before sequences represent the location of the ﬁrst amino acid in the sequence within the large tegument protein. Whenever possible, sequences of reference strains were
used for each virus and the GenBank ID numbers are shown.
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USP as part of the N-terminus the large tegument pUL36. Muta-
tion of the cysteine residue to alanine (C98A) in the active site
abrogated DUB activity and led to a mild decrease of lytic
replication in vitro and severe impairment of tumorigenesis in
chickens (Jarosinski et al., 2007a).
The MDV-encoded USP belongs to the highly conserved her-
pesvirus tegument USPs family, whose ﬁrst member was discov-
ered in herpes simplex virus type 1 (HSV-1, human herpesvirus
type 1, HHV-1) as part of the N-terminus of its major tegument
protein VP1/2, encoded by UL36 (Kattenhorn et al., 2005). HSV-1
USP is expressed independently of VP1/2 as a 47 KDa protein,
can be detected as early as 12 h post-infection (pi) and is speciﬁc
for K48 and K63 polyubiquitin chains (Bolstad et al., 2011;
Kattenhorn et al., 2005; Kim et al., 2009). USPs are encoded as
part of the major tegument protein by all known herpesviruses
(Fig. 1) and share no sequence and structural homology to other
eukaryotic USPs (Kattenhorn et al., 2005; Schlieker et al., 2007).
Their properties have been analyzed in several members of the
order Herpesvirales besides HSV-1 (Kattenhorn et al., 2005) and
MDV (Jarosinski et al., 2007a): the alphaherpesviruses pseudora-
bies virus (PRV, Suid herpesvirus type 1, SuHV-1) (Bottcher et al.,
2008); the betaherpesviruses human cytomegalovirus (HCMV,
HHV-5) (Wang et al., 2006), murine cytomegalovirus (MCMV,
Murid herpesvirus 1, MuHV-1) (Schlieker et al., 2007) and simian
cytomegalovirus (SCMV, Cercopithecine herpesvirus 5, CeHV-5)
(Wang et al., 2006) and the gammaherpesviruses Epstein-Barr
virus (EBV, HHV-4) (Schlieker et al., 2005), Kaposi’s sarcoma-
associated virus (KSHV, HHV-8) (Gonzalez et al., 2009) and mouse
herpesvirus strain 68 (MHV-68, Murid herpesvirus type 4, MuHV-4)
(Gredmark-Russ et al., 2009). All studied herpesvirus USPs have
high speciﬁcity for (Ub chains, but not for the Ub-like molecules
SUMO1 or ISG15 (Kattenhorn et al., 2005; Schlieker et al., 2005). In
addition, USPs encoded by EBV, KSHV, HSV-1 and MCMV also
interact with the Ub-like molecule NEDD8, which has high
sequence identity to Ub (Gastaldello et al., 2012, 2010). Mutation
of the conserved cysteine residue of USPs in most herpesviruses so
far studied results in impaired viral replication in vitro, with the
exception of HSV-1, in which this mutation abrogates enzymatic
activity (Kattenhorn et al., 2005), but does not affect HSV-1
replication in terms of plaque size assays and growth kinetics
(Bolstad et al., 2011). Furthermore, several USPs including MDV
USP have been shown to play an important role in virus pathogen-
esis. In the absence of USP activity, PRV is deﬁcient for neuroinva-
sion properties in the mouse model system (Bottcher et al., 2008),
while MHV-68 USP mutants are not able to establish a persistent
infection in intraperitoneal infected C57/BL6 mice (Gredmark-Russ
et al., 2009).Despite the drastic reduction in MDV-induced tumorigenesis
in the absence of USP activity, the exact role(s) of the protease in
MDV replication and tumorigenesis has remained unknown. In
order to investigate the roles of MDV USP in virus replication and
oncogenesis, we generated a panel of recombinant (r) MDVs and
investigated their replication properties and pathogenesis in
infected chickens. We could demonstrate that the N-terminus of
MDV pUL36, as well as the region within the N-terminus encom-
passing the catalytic domain of USP, is essential for MDV replica-
tion, suggesting that it plays an important structural role at the
N-terminal portion of the UL36 protein. However, it still remains
uncertain as to why MDV tumorigenesis is impaired in the
absence of a functional USP.Results
The N-terminus of pUL36 is essential for MDV replication
We previously demonstrated the USP in MDV is encoded in the
322 N-terminal amino acid (aa) residues of pUL36, with the
conserved cysteine at position 98 (C98) being essential for DUB
activity (Jarosinski et al., 2007a) (Fig. 1). To determine whether USP
sequence at the N-terminus of pUL36 is essential for viral replica-
tion, we deleted the complete USP coding sequence (rDUSP) in
the infectious bacterial artiﬁcial chromosome (BAC) clone of the
highly oncogenic RB-1B strain (pRB-1B) (Jarosinski et al., 2007b;
Petherbridge et al., 2003). In addition, a revertant (rDUSP-rev) was
generated in which the USP sequence was restored. Following
reconstitution of the viruses (v) by transfection of rMDV BAC DNA
into chicken embryo cells (CECs), we observed that vDUSP was
unable to replicate in vitro, since only individually infected cells
were detected. In contrast, vDUSP-rev replicated comparable to
parental vRB-1B in plaque size assays (Fig. 2B). Our data suggested
that the N-terminal region of the major tegument protein UL36 is
essential for MDV replication, since USP activity itself is not required
for virus replication (Jarosinski et al., 2007a).
Ectopically-expressed USP does not restore replication or
oncogenicity of vC98A
We previously demonstrated that rMDV with mutation of the
conserved cysteine in the active site (vC98A) was severely
impaired in its ability to induce lymphomas (Jarosinski et al.,
2007a). However, it remained unclear whether MDV USP is
required to be part of pUL36 to fulﬁll its functions in MDV
replication and tumorigenesis. To address this question, we
ectopically expressed a codon-optimized synthetic USP (SynUSP)
Fig. 2. Importance of MDV USP for viral replication. (A) Schematic representa-
tion of pUL36 in vRB-1B, vDUSP and vDUSP-rev. (B) Plaque sizes are shown as
mean plaque diameters obtained in each experiment. Wild-type plaque sizes were
set at 100%. Whiskers show 5 and 95% percentile values. Signiﬁcant differences in
replication (Kruskal–Wallis test, po0.05) are indicated with an asterisk (*).
Fig. 3. Ectopic expression of SynUSP.HA at the N-terminus of UL36 cannot
rescue defective in vitro replication of vC98A. (A) Schematic representation of
pUL36 in vRB-1B, vC98A and vC98A-SynUSP.HA. (B) Plaque size analysis of vRB-
1B, vC98A and vC98A-SynUSP.HA in CKCs, showing that ectopic SynUSP expres-
sion in vC98A does not restore replication to wild-type levels. Plaque sizes are
shown as in Fig. 2. Signiﬁcant differences between vRB-1B, vC98A and vC98A-
SynUSP.HA (Mann–Whitney U test, po0.05) are indicated with an asterisk (*).
Fig. 4. Ectopic expression of SynUSP.HA at the N-terminus of UL36 cannot
rescue in vivo replication and tumorigenesis of vC98A. (A) qPCR analysis of
MDV genome copy numbers in whole blood of chickens infected with vRB-1B,
vC98A or two independent clones of vC98A-SynUSP.HA. The mean MDV genome
copy numbers per 1106 cells of ten infected chickens per group are shown with
standard deviations. Signiﬁcant differences between vRB-1B and other groups
(Mann–Whitney U tests, p40.05) are indicated with an asterisk (*). (B) Tumor
incidence of chickens (n¼10 per group) infected with vRB-1B, vC98A, or both
vC98A-SynUSP.HA clones over the course of 13 weeks.
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into the MDV genome. In addition to SynUSP, an HA tag was
included at the C-terminus (SynUSP.HA). SynUSP.HA was ﬁrst
introduced at the 50 end of UL36 in rC98A to generate (rC98A-
SynUSP.HA). rC98A-SynUSP.HA expressed SynUSP under the con-
trol of the UL36 promoter and contained two stop codons
following the synthetic sequence, which separated SynUSP from
the rest of the UL36 open reading frame (Fig. 3A). Reconstitution
of rC98A-SynUSP.HA (vC98A-SynUSP.HA) resulted in viable virus
and SynUSP.HA expression could be detected both by western
blot and immunoﬂuorescence (IF) assays (Supplemental Fig. 1).
Plaque size assays showed that vC98A-SynUSP.HA replicated
comparable to vC98A, but had a signiﬁcant growth defect com-
pared to parental vRB-1B, suggesting that ectopic expression ofSynUSP.HA at the 50 end of UL36 does not complement DUB
activity of vC98A (Fig. 3B).
To determine whether ectopic expression of SynUSP had an
effect on MDV pathogenesis, we infected one day old chickens
with vRB-1B, vC98A and two independent clones of vC98A-
SynUSP.HA (clones 1 and 2) and measured in vivo replication
and tumorigenesis. Replication of vC98A-SynUSP.HA in infected
chickens was signiﬁcantly reduced when compared to vRB-1B
(Fig. 4A) and was comparable to vC98A. Lymphomagenesis
of both vC98A-SynUSP.HA independent clones was severely
impaired compared to vRB-1B and was comparable to vC98A
(Fig. 4B). Our results demonstrate that ectopic expression of USP,
as a separate protein outside the context of pUL36, was unable to
restore efﬁcient MDV replication and tumorigenesis of vC98A,
a virus lacking DUB activity.
There are a number of possible explanations for the observa-
tion that SynUSP.HA was expressed in cells infected with vC98A-
SynUSP.HA, but did not restore replication of the C98A mutant
virus. First, insertion of SynUSP.HA upstream of the UL36 transla-
tion start codon could have an effect on pUL36 expression.
Second, the presence of the C-terminal HA tag on SynUSP could
affect the enzymatic function of SynUSP. We were unable to
Fig. 5. HA removal from rC98A-SynUSP.HA or IRES insertion upstream from
pUL36 do not restore wild-type replication. (A) Schematic representation of
pUL36 from vRB-1B, vC98A, vC98A-SynUSP.HA, vC98A-SynUSP and vC98A-IRES.-
SynUSP.HA. (B) Plaque size assays of indicated viruses as shown in Fig. 2. HA
removal (vC98A-SynUSP) modestly improves viral replication when compared to
vC98A-SynUSP.HA (Mann–Whitney U test, p40.05), but does not restore replica-
tion to wild-type (vRB-1B) levels (Mann–Whitney U test, po0.05). The insertion
of the IRES sequence (vC98A-IRES.SynUSP.HA) did not result in improvement
when compared to vC98A-SynUSP.HA or vRB-1B.
Fig. 6. Replacement of MDV USP with SynUSP does not alter in vitro replica-
tion. (A) Schematic representation of pUL36 from vRB-1B, vSynUSP.link and
vSynUSP.link-rev. (B) Multi-step growth kinetics of vRB-1B, vSynUSP.link and
vSynUSP.link-rev in CEC cultures. No signiﬁcant differences between the three
viruses were observed (Kruskal–Wallis test, p40.05). (C) Plaque size assays of
indicated viruses are shown as in Fig. 2. A signiﬁcant difference between
vSynUSP.link compared to wild-type (vRB-1B) and revertant (vSynUSP.link-rev)
viruses (Mann–Whitney U test, po0.05) was observed.
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pUL36 are available. Therefore, we inserted an internal ribosome
entry sequence (IRES) element between the SynUSP and pUL36 to
create rC98A-IRES.SynUSP.HA (Fig. 5A) with the hope of facilitat-
ing more efﬁcient translation of pUL36. To address the question of
whether the HA-tag impaired the enzymatic function of USP, we
removed the HA tag from rC98A-SynUSP.HA to generate rC98A-
SynUSP. Both rMDVs were reconstituted and plaque size assays
showed that insertion of the IRES did not improve viral replication
(Fig. 5B). In contrast, HA removal resulted in slightly increased
plaque sizes, although this did not completely restore replication
to vRB-1B levels (Mann–Whitney U test, p40.05). Taken
together, this data supports the hypothesis that the reduced
replication of vC98A-SynUSP.HA is the result of the absence of
an active USP embedded within the N-terminus of pUL36.
The nucleotide sequence of USP is not important for replication
in vitro
Since removal of the complete USP sequence resulted in non-
viable virus, we tested whether the nucleotide sequence of MDV
USP was important for MDV replication by replacing the wild-
type USP sequence with the SynUSP sequence (rSynUSP.link) as
well as generated a revertant virus (vSynUSP.link-rev) (Fig. 6A).
Following reconstitution of the recombinant viruses in CECs,
vSynUSP.link replicated with kinetics that were comparable to
parental and revertant viruses based on multi-step growth
kinetics assays (Fig. 6B; Kruskal–Wallis test, p40.05); however,
plaque sizes were signiﬁcantly different (Fig. 6C). In all, these data
suggest the exact USP base pair sequence is most likely not
important for MDV replication.The USP cysteine box is required for viral replication
Herpesvirus USPs encode a highly conserved region called the
cysteine (Cys) box (Kattenhorn et al., 2005) that encompasses the
active site cysteine (C98) and is located between a glutamine
(Q85) and a leucine (L106) residue. To determine the role of the
Cys box in MDV replication in vitro, we deleted the 22 aa from the
conserved Q85 to L106 residues in pRB-1B (rDCysBox) and also
generated a revertant virus (rDCysBox-rev) (Fig. 7A). Following
reconstitution of rMDVs in CECs, we observed that rDCysBox was
unable to replicate in vitro as only individually infected cells were
detected. In contrast, rDCysBox-rev replicated comparable to
parental vRB-1B in plaque size assays (Fig. 7B). Since abrogation
of USP activity still results in viable virus, our data suggest that
cysteine box of USP possesses either functions beyond DUB
activity or has a structural role at the N-terminus of pUL36.Discussion
In recent years, herpesvirus tegument USPs have garnered
much interest, not only due to their function in virus replication
and pathogenesis, but also as possible targets for antiviral therapy
(Schlieker et al., 2007). So far it remains unclear whether
Fig. 7. MDV USP cysteine box is essential for in vitro replication. (A) Schematic
representation of pUL36 in vRB-1B, vDCysBox and vDCysBox-rev. (B) Plaque size
assays of vRB-1B, DCysBox and vDCysBox-rev after transfection in CECs are shown
as in Fig. 2. Signiﬁcant differences (Mann–Whitney U test, po0.05) are indicated
with an asterisk (*).
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tegument protein, expressed as a separate protein, or perform
their major functions in the context of the protein. HSV-1 USP has
been shown to be expressed independently (Kattenhorn et al.,
2005) and as a post-translationally cleaved form of pUL36, both of
which have DUB activity (Wang et al., 2006). Mutation of the
cysteine to alanine in the active site of HSV-1 USP does not affect
viral replication (Bolstad et al., 2011). For HCMV, both the non-
cleaved form and a 38 kDa catalytic fragment were found to
interact with an HA-tagged Ub-vinylmethyl esther (HAUbVME)
DUB detection probe, previously used for identiﬁcation of other
USPs (Kattenhorn et al., 2005; Schlieker et al., 2005) and struc-
tural studies (Schlieker et al., 2007). In the case of SCMV, only the
uncleaved active form of the large tegument protein was found to
bind HAUbVME (Wang et al., 2006). In addition, a 325 aa N-
terminal fragment of EBV BPLF1 transfected in HeLa cells could
actively cleave both Ub and NEDD8 bounded to green ﬂuorescent
protein (Gastaldello et al., 2012, 2010). Taken together, these
observations indicate that some herpesvirus tegument USPs can
be expressed independently from the large tegument protein in
all herpesviruses subfamilies.
It was initially thought that USPs play a role in the protection
of viral and cellular proteins from degradation by the proteasome
(Kattenhorn et al., 2005; Komander et al., 2009) and considerable
efforts have been devoted to discover interaction partners
(Bolstad et al., 2011; Gastaldello et al., 2010; Schat et al., 1981;
Whitehurst et al., 2009). Furthermore, afﬁnity of herpesvirus USPs
for certain Ub chains has been addressed; however, data on the
chain speciﬁcity is generally controversial (Bolstad et al., 2011;
Kattenhorn et al., 2005; Kim et al., 2009; Schlieker et al., 2007;
Wang et al., 2006). Many herpesvirus USP substrates have been
identiﬁed for gammaherpesviruses. BPLF1 of EBV was found to
interact with the viral-encoded ribonucleotide reductase
(Whitehurst et al., 2009). BPLF1 also acts as a deneddylase and
interferes with cullin-RING E3 ligases neddylation cycle by
inhibition of the Cullin-associated NEDD8-dissociated protein 1
(CAND1), which leads to cell cycle arrest in S phase that is
favorable for viral replication (Gastaldello et al., 2012, 2010).
More recently, BPLF1 was also found to deubiquitinate the
cellular proliferating cell nuclear antigen (PCNA), which isessential for recruitment of the specialized translesion poly-
merases upon DNA damage (Whitehurst et al., 2012). These
studies indicate that the USP encoded by EBV is involved, not
only in multiple steps of virus replication, but can also eventually
hinder DNA repair mechanisms. Studies performed with HSV-1-
encoded USP and MCMV-M48 indicate that deneddylase activity
and S-phase deregulation are common for herpesvirus USPs
(Gastaldello et al., 2012, 2010). The KSHV USP, encoded by
ORF64, down-regulates RIG-I-mediated signaling by decreasing
RIG-I activation (Schat et al., 1981), which was interpreted such
that USPs can contribute to avoidance of cellular immune
responses during viral infection. A recent report showed that
HSV-1 USP plays an important role in stabilizing pUL36 (Bolstad
et al., 2011), which also seems to be the case for the PRV pUL36
ortholog (Nicholas Huffmaster and Gregory Smith, personal com-
munication). HSV-1 USP was also recently described to interact
with TSG101 in HSV-1, thereby interfering with multivesicular
body (MVB) formation and, consequently, viral envelopment and
budding (Caduco et al., 2013).
Regarding MDV USP, no interaction partners have been iden-
tiﬁed so far. The only published report on MDV USP showed that
abrogation of USP activity by the mutation of the cysteine in the
active DUB site (vC98A) had severe impact on viral pathogenesis
(Jarosinski et al., 2007a). One explanation for this phenotype is
that MDV USP could deregulate the cell cycle by deubiquitination
of cellular and/or viral proteins, thereby protecting them from
proteasome degradation; therefore vC98A is unable to evade the
proteasome. Our report here clearly shows that the removal of the
N-terminal 322 aa from the pUL36 (DUSP) was lethal for virus
replication (Fig. 2). Similarly, removal of only 22 aa encoding the
USP cysteine box of the 3358 aa long pUL36 of MDV also had a
lethal effect on virus replication (Fig. 7). The fact that deletion of
the complete USP region (322 aa) or the USP cysteine box (22 aa)
within pUL36 are essential for virus replication, whereas an
enzymatically inactive DUB still allows virus replication suggests
a structural, rather than enzymatic, role of USP in MDV replica-
tion. Although we currently cannot formally prove this to be the
case, we surmise that the USP domain is a functional part of
pUL36 and may play a role in virus assembly (tegumentation) or
virus entry and egress, as described for HSV-1 (Desai, 2000;
Roberts et al., 2009) and PRV (Bottcher et al., 2008). Based on
the results presented here, we concluded that the N-terminus of
pUL36 containing USP is essential for MDV replication and that its
importance in this role is likely tied to acting directly on the
pUL36 of MDV, similarly to what has been described for HSV-1
USP (Bolstad et al., 2011). Unfortunately, it was not possible to
determine whether pUL36 is correctly expressed in vC98A-
SynUSP.HA due to the lack of speciﬁc MDV pUL36 antibodies.
Furthermore, it is currently not possible to investigate the func-
tional role of MDV USP during transformation as alterations in the
USP region severely affect MDV replication (Jarosinski et al.,
2007a). Our strategy of complementing USP function by ectopi-
cally expressing SynUSP did not result in restoration of tumor-
igenesis (Fig. 4); therefore, the exact role of MDV USP in
tumorigenesis is still unclear at this time. Intriguingly, replace-
ment of MDV USP at the N-terminus of the UL36 gene by SynUSP
resulted in a virus with replication properties comparable to
parental vRB-1B and revertant viruses, suggesting that USP is
required as an integral part of pUL36. It is possible that the proper
function of USP requires proper localization that pUL36 provides
as there are no predicted nuclear localization (NLS) or nuclear
export (NES) signals in the USP sequence. In future experiments, it
will be important to determine if ectopic expression of SynUSP
results in co-localization with full-length pUL36. Unfortunately,
all attempts to generate anti-MDV pUL36 antibodies have failed
so far.
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N-terminus of MDV pUL36 for virus replication with four impor-
tant ﬁndings. First, we could demonstrate that N-terminal 322 aa
is essential for MDV replication. Second, ectopic expression of a
synthetic USP did not restore virus replication in a replication-
defective virus, suggesting that MDV USP requires being an
integral part of the pUL36 large tegument protein. Third, the
nucleotide sequence of USP is not important for virus replication.
Fourth, we could demonstrate that the cysteine box encompass-
ing a 22 aa region of MDV USP is also essential for replication
in vitro, underlining the role of USP at the N-terminus of pUL36.Material and methods
Cells and viruses
Primary CECs and chick kidney cell (CKC) cultures were
prepared from speciﬁc pathogen-free (SPF) eggs or chickens using
standard methods (Schat KA, 1998). Cells were grown in minimal
essential medium supplemented with 5% fetal calf serum (FCS)
and 1% penicillin/streptomycin at 37 1C in a 5% CO2 atmosphere.
rMDVs were reconstituted in CECs by calcium phosphate trans-
fection of BAC DNA as described previously (Sambrook, 2001) and
propagated in either CECs or CKCs.Generation of rMDVs
USP mutant viruses were generated based on the spread
competent pRB-1B (Jarosinski et al., 2007b), an infections BAC
clone of the very virulent RB-1B strain (Petherbridge et al., 2003)
by two-step red-mediated recombination in GS1783 Escherichia
coli as previously described (Tischer et al., 2010, 2006). rMDV BAC
clones were analyzed by PCR, restriction fragment length poly-
morphism (RFLP) analysis, and DNA sequencing. Primers used for
generation of transfer plasmids, mutagenesis and sequencing are
shown in Table 1. For generation of rMDVs with deletions (rDUSP,
rDCysBox, rC98A-SynUSP, rSynUSP.link), PCR products were
ampliﬁed from pEPkan-S as described (Jarosinski et al., 2007b)
using the corresponding primers (Table 1). For rDUSP, the N-
terminal 966 bp of MDV UL36 gene was removed (Jarosinski et al.,
2007a). For rDCysBox generation, the 66 bp (22 aa) from gluta-
mine 85 (Q85) to leucine 106 (L106) including cysteine (C98) in
the active site were removed (Kattenhorn et al., 2005). Further-
more, the HA-tag was removed from rSynUSP.HAlink and rC98A-
SynUSP.HA, resulting in rSynUSP.link and rC98A-SynUSP,
respectively.
For the insertion of ectopically expressed SynUSP in rMDVs, a
transfer plasmid was generated, as previously described (Tischer
et al., 2006). Brieﬂy, codon-optimized, C-terminal HA-tagged
synthetic USP (SynUSP.HA) was obtained from GeneArts Gene
Synthesis (Regensburg, Germany) in the pGA4 vector (pGA4-
SynUSP.HA). The aphAI and I-SceI restriction site were ampliﬁed
from pEPKan-S and inserted into the unique BglII site of pGA4-
SynUSP.HA to generate the transfer plasmid pSynUSP.HA. For the
generation rC98A-IRES.SynUSP.HA, a transfer plasmid, named pBS
II KS(þ) IRES2-K-eGFP, was used as a template for ampliﬁcation
of the IRES-aphAI/I-SceI cassette. Brieﬂy, the encephalomyocardi-
tis virus IRES-eGFP fragment from pCeMM-CTAP (SG)
(Burckstummer et al., 2006; Naviaux et al., 1996) was inserted
into pBS II KS(þ) (Stratagene, La Jolla, CA) using PmlI and NaeI
restriction enzymes. Next, the aphAI-I-SceI cassette was ampliﬁed
from pEPkan-SII using primers in Table 1 and inserted using the
unique AvrII restriction site within the IRES. Speciﬁc primers were
used to amplify the IRES-aphAI-I-SceI cassette from pBS II KS(þ)IRES2-K-eGFP to insert the IRES sequence upstream of the
UL36 ORF.
For the generation of revertant viruses (rSynUSP.link-rev,
rDUSP-rev, DCysBox-rev), transfer plasmid pMDV USP was gen-
erated as described previously (Tischer et al., 2006). Brieﬂy, wild-
type MDV USP was cloned into pGex-6p-1 (GE Healthcare, Little
Chalfont, UK) and the aphAI/I-SceI cassette was cloned from
pEPKan-S into a unique EcoRI restriction site.
Indirect immunoﬂuorescence (IF) and plaque size assays
Plaque size assays were performed as described previously
(Inn et al., 2011). One-hundred plaque forming units (PFU) viruses
were co-seeded in 3 wells of a 6-well plate with 1106 primary
CECs or CKCs. After six days, cells were ﬁxed with 90% ice-cold
acetone for 10 min at 20 1C and air-dried. For non-viable rMDV,
1106 primary CECs were transfected with BAC DNA using the
calcium phosphate method and plaques ﬁxed after six days post
transfection. Standard IF assays were performed using polyclonal
anti-MDV chicken serum and anti-chicken IgY Alexa 488 (Invitro-
gen Inc., Carlsbad CA, USA),both diluted in blocking solution
(3% FCS in PBS). Images of at least 60 individual plaques from each
virus were collected. For non-viable virus, at least 20 individually
infected cells were evaluated post transfection. Images were
recorded using an Axio-Observer Z1 ﬂuorescence microscope
(Zeiss, Jena, Germany) at 100 magniﬁcation and relative plaque
areas were measured using NIH Image J 1.410 software (Abramoff
et al., 2004). All plaque areas were compared to wild-type virus
plaque areas. Data were displayed in graph form using GraphPad
Prism (GraphPad Software, Inc., La Jolla CA, USA) and SPSS (IBM,
Armonk NY, USA) was used for statistical analyses. All experi-
ments described above were performed at least three times
independently.
Multi-step growth kinetics assays
One million primary CECs were infected with 100 PFU viruses,
trypsinized at 24 h intervals for 6 days and titrated in primary
CECs. After six days post-titration, plaques were stained by IF and
number of plaques determined.
Animal studies
SPF P2a chickens (MHC: B19B19) were obtained from Cornell
University’s departmental ﬂocks and housed in isolation units.
Water and food were provided ad libitum. All experiments where
performed in accordance with approved Institutional Animal Care
and Use Committee (IACUC) protocols (Cornell University Proto-
col number: 2008-0018). Ten 1-day-old chicks were infected
intra-abdominally with 2000 PFU of rMDV and placed into dif-
ferent units with ﬁve age-matched, uninfected contact birds.
Whole blood was collected by wing-vein puncture as previously
described (Jarosinski et al., 2007b) from ten birds per group at 4,
7, 10, 14, 21, 28 and 35 days pi. Chickens were evaluated twice
daily for clinical signs of disease and euthanized as soon as
symptoms became apparent. At 13 weeks pi, the experiment
was terminated and necropsies were performed on all
remaining birds.
Quantitative PCR (qPCR) analysis
DNA was extracted from chicken whole blood and MDV
genomic copies measured using qPCR assays as described pre-
viously (Jarosinski et al., 2007a, 2007b, 2005). Brieﬂy, MDV
genome copies were determined using primers and probe speciﬁc
for the MDV-infected cell protein 4 gene and normalized against
Table 1
Primers used for transfer plasmid generation, sequencing, and two-step red mutagenesis.
Construct Purposea Directionb Sequenc (50-30)c
pSynUSP.HA Transfer
Plasmid
Forward CGAGCAGATCTGGAAGAAGAAGAGGGGCGACGTCTACTGCCTGATCGTGGTAGGGATAACAGGGTAATCGATTT
Reverse TGCACGAGATCTGCCAGTGTTACAACCAATTAACC
pBS II KS(þ) IRES2-K-
eGFP
Transfer
Plasmid
Forward ATTAACCTAGGGGTCTTTCCCCTCTCGCTAGGGATAACAGGGTAATCGATTT
Reverse TATTTCCTAGGAATGCTCGTCAAGAAGACGCCAGTGTTACAACCAATTAACC
pMDV USP Transfer
Plasmid
Forward TTTTTGAATTCTATCTAGAAGAAAACACGCCCACTATAGGGATAACAGGGTAATCGATTTA
Reverse AAAAAGAATTCAAACTCCCCATATGAACTCGAAAATGCCAGTGTTACAACCAATTAACCAA
MDV USP/SynUSP N
terminal seq
Sequencing Forward GTAGGAGCATCATTATACGAAAGAT
Reverse CGACGCATATTTTCAATCAT
SynUSP seq (internal) Sequencing Forward GTAGGTGCCGTCCTCGCTTGTGGCG
Reverse CGCCACAAGCGAGGACGGCACCTAC
MDV USP (internal) Sequencing Forward CTCAACGAGCTGCTTGATCC
Reverse GGCATATAGGACAGGCATGTATAG
SynUSP-UL36
junction seq
Sequencing Forward TTGATATAATTCTATTCGGC
Reverse CGCCACAAGCGAGGACGGCACCTAC
rC98A-SynUSP rMDV Forward AGTAGCTTGTCTGCTGTCAGTAGAATCTGTCATTTCATCAGTCGGCGGACACCACCTTGCTAGGGATAACAGGGTAATCG
Reverse GGCCAGGGAAGAGGACAACCGCAAGGTGGTGTCCGCCGACTGATGAAATGACAGATTCTAGCCAGTGTTACAACCAATTA
rC98A-
IRES.SynUSP.HA
rMDV Forward AATTTGTAGTAGCTTGTCTGCTGTCAGTAGAATCTGTCATGTTGTGGCCATATTATCATC
GCCGACTACCCCTACGACGTGCCCGACTACGCCTGATGAACCGCCCCTCTCCCTCCCCC
rDUSP rMDV Forward TGACAAGTTTGGTTAATCTCGGTTGTGGCCTAGAAGGCGGCATTTTACACTCAATTTATATAGGGATAACAGGGTAATCG
Reverse TCGACGCATATTTTCAATCATATAAATTGAGTGTAAAATGCCGCCTTCTAGGCCACAACCGCCAGTGTTACAACCAATTA
rDUSP-rev rMDV Forward TGACAAGTTTGGTTAATCTCGGTTGTGGCCTAGAAGGCGGATCAAAATCTGCCGACACTA
Reverse TCGACGCATATTTTCAATCATATAAATTGAGTGTAAAATGACAGATTCTACTGACAGCAG
rC98A-SynUSP. HA rMDV Forward GAGCTTATGTCGTTTCGACGCATATTTTCAATCATATAAATTGAGTGTAAGCCACCATGACCGACAGCAC
Reverse ATTTCCTGCAATTTGTAGTAGCTTGTCTGCTGTCAGTAGAATCTGTCATTTCATCAGGCGTAGTCGGGCA
rSynUSP.HA link rMDV Forward TTTGGTTAATCTCGGTTGTGGCCTAGAAGGCGGATCAAAGGCGTAGTCGGGCACGTCGTAGGGATAACAGGGTAATCGATTT
Reverse AGGTGGTGTCCGCCGACTACCCCTACGACGTGCCCGACTACGCCTTTGATCCGCCTTCTAGGCGCCAGTGTTACAACCAATTAACC
rSynUSP. link rMDV Forward GTTTGGTTAATCTCGGTTGTGGCCTAGAAGGCGGATCAAAGTCGGCGGACACCACCTTGCTAGGGATAACAGGGTAATCGATTT
Reverse GGCCAGGGAAGAGGACAACCGCAAGGTGGTGTCCGCCGACTTTGATCCGCCTTCTAGGCCGCCAGTGTTACAACCAATTAACC
rSynUSP. link-rev rMDV Forward GTTTGGTTAATCTCGGTTGTGGCCTAGAAGGCGGATCAAAATCTGCCGACACTACTTTAC
Reverse GACGCATATTTTCAATCATATAAATTGAGTGTAAGCCACCATGACAGATTCTACTGACAG
rDCysBox rMDV Forward ATGATATGACTGTATCTAATCCATACGCAAAAACTATACGGTTTCTAATACCAACCGCCATAGGGATAACAGGGTAATCG
Reverse TACGACTGATGTAACGGTAGTGGCGGTTGGTATTAGAAACCGTATAGTTTTTGCGTATGGGCCAGTGTTACAACCAATTA
rDCysBox-rev rMDV Forward CACTTACACGGACTATACATGCCTG
Reverse ATGACAGATTCTACTGACAGCAGAC
a Primers were used for construction of transfer plasmids, sequencing, or generation of rMDV using two-step Red recombination.
b Directionality of the primer.
c Underlined nucleotides indicate important pEP-kan-S binding sites used in two-step red mutagenesis.
I.B. Veiga et al. / Virology 437 (2013) 110–117116the cellular inducible nitric oxide synthase gene. qPCR reactions
were performed in an ABI Prism 7500 Fast Real-time PCR system
(Applied Biosystems, Carlsbad CA, USA).Acknowledgments
I.B.V. would like to thank the Fundac- ~ao para a Cieˆncia e
Tecnologia (FCT) from Portugal for funding these studies. The
authors wish to thank Walid Azab, Timo Schippers and Ann Reum
for help with the generation of rMDVs, as well as Annachiara
Greco, Annemarie T. Engel, and Armando Damiani for helping
with statistics.Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.virol.2013.01.003.References
Abramoff, M.D.M., Paulo, J., Ram, J., 2004. Image processing with Image. J.
Biophotonics Int. 11 (7), 36–42.
Bolstad, M., Abaitua, F., Crump, C.M., O’Hare, P., 2011. Autocatalytic activity of the
ubiquitin-speciﬁc protease domain of herpes simplex virus 1 VP1-2. J. Virol. 85
(17), 8738–8751.
Bottcher, S., Maresch, C., Granzow, H., Klupp, B.G., Teifke, J.P., Mettenleiter, T.C.,
2008. Mutagenesis of the active-site cysteine in the ubiquitin-speciﬁc protease
contained in large tegument protein pUL36 of pseudorabies virus impairsviral replication in vitro and neuroinvasion in vivo. J. Virol. 82 (12),
6009–6016.
Bucks, M.A., O’Regan, K.J., Murphy, M.A., Wills, J.W., Courtney, R.J., 2007. Herpes
simplex virus type 1 tegument proteins VP1/2 and UL37 are associated with
intranuclear capsids. Virology 361 (2), 316–324.
Burckstummer, T., Bennett, K.L., Preradovic, A., Schutze, G., Hantschel, O., Superti-
Furga, G., Bauch, A., 2006. An efﬁcient tandem afﬁnity puriﬁcation procedure
for interaction proteomics in mammalian cells. Nat. Methods 3 (12),
1013–1019.
Caduco, M., Comin, A., Toffoletto, M., Munegato, D., Sartori, E., Celestino, M., Salata,
C., Parolin, C., Palu, G., Calistri, A., 2013. Tsg101 interacts with herpes simplex
virus 1 VP1/2 and is a substrate of VP1/2 ubiquitin-speciﬁc protease domain
activity. J. Virol. 87 (1), 692–696.
Cardone, G., Newcomb, W.W., Cheng, N., Wingﬁeld, P.T., Trus, B.L., Brown, J.C.,
Steven, A.C., 2012. The UL36 tegument protein of herpes simplex virus 1 has a
composite binding site at the capsid vertices. J. Virol. 86 (8), 4058–4064.
Chau, V., Tobias, J., Bachmair, A., Marriott, D., Ecker, D., Gonda, D., Varshavsky, A.,
1989. A multiubiquitin chain is conﬁned to speciﬁc lysine in a targeted short-
lived protein. Science 243 (4898), 1576–1583.
Clinton, M., Zhao, D., McBride, D., Nandi, S., McQueen, H.A., McGrew, M.J., Hocking,
P.M., Lewis, P.D., Sang, H.M., 2010. Somatic sex identity is cell autonomous in
the chicken. Nature 464 (7286) 237-U115.
Colleaux, L., d’Auriol, L., Betermier, M., Cottarel, G., Jacquier, A., Galibert, F., Dujon,
B., 1986. Universal code equivalent of a yeast mitochondrial intron reading
frame is expressed into E. coli as a speciﬁc double strand endonuclease. Cell 44
(4), 521–533.
Costa, M.C., Paulson, H.L., 2011. Toward understanding Machado–Joseph disease.
Prog. Neurobiol. 97 (2), 239–257.
Davison, A.J., Eberle, R., Ehlers, B., Hayward, G.S., McGeoch, D.J., Minson, A.C.,
Pellett, P.E., Roizman, B., Studdert, M.J., Thiry, E., 2009. The order herpesvirales.
Arch. Virol. 154 (1), 171–177.
Desai, P.J., 2000. A null mutation in the UL36 gene of herpes simplex virus type
1 results in accumulation of unenveloped DNA-ﬁlled capsids in the cytoplasm
of infected cells. J. Virol. 74 (24), 11608–11618.
Fragnet, L., Blasco, M.A., Klapper, W., Rasschaert, D., 2003. The RNA subunit of
telomerase is encoded by Marek’s disease virus. J. Virol. 77 (10), 5985–5996.
I.B. Veiga et al. / Virology 437 (2013) 110–117 117Gastaldello, S., Callegari, S., Coppotelli, G., Hildebrand, S., Song, M., Masucci, M.G.,
2012. Herpes virus deneddylases interrupt the cullin-RING ligase neddylation
cycle by inhibiting the binding of CAND1. J. Mol. Cell. Biol. 4 (4), 242–251.
Gastaldello, S., Hildebrand, S., Faridani, O., Callegari, S., Palmkvist, M., Di
Guglielmo, C., Masucci, M.G., 2010. A deneddylase encoded by Epstein–Barr
virus promotes viral DNA replication by regulating the activity of cullin-RING
ligases. Nat. Cell. Biol. 12 (4), 351–361.
Glickman, M.H., Ciechanover, A., 2002. The ubiquitin-proteasome proteolytic
pathway: destruction for the sake of construction. Physiol. Rev. 82 (2),
373–428.
Gonzalez, C.M., Wang, L., Damania, B., 2009. Kaposi’s sarcoma-associated herpes-
virus encodes a viral deubiquitinase. J. Virol. 83 (19), 10224–10233.
Gredmark-Russ, S., Isaacson, M.K., Kattenhorn, L., Cheung, E.J., Watson, N., Ploegh,
H.L., 2009. A gammaherpesvirus ubiquitin-speciﬁc protease is involved in the
establishment of murine gammaherpesvirus 68 infection. J. Virol. 83 (20),
10644–10652.
Inn, K.S., Lee, S.H., Rathbun, J.Y., Wong, L.Y., Toth, Z., Machida, K., Ou, J.H., Jung, J.U.,
2011. Inhibition of RIG-I-mediated signaling by Kaposi’s sarcoma-associated
herpesvirus-encoded deubiquitinase ORF64. J. Virol. 85 (20), 10899–10904.
Isaacson, M.K., Ploegh, H.L., 2009. Ubiquitination, ubiquitin-like modiﬁers, and
deubiquitination in viral infection. Cell Host Microbe 5 (6), 559–570.
Jarosinski, K., Kattenhorn, L., Kaufer, B., Ploegh, H., Osterrieder, N., 2007a. A
herpesvirus ubiquitin-speciﬁc protease is critical for efﬁcient T cell lymphoma
formation. Proc. Nat. Acad. Sci. U.S.A. 104 (50), 20025–20030.
Jarosinski, K.W., Margulis, N.G., Kamil, J.P., Spatz, S.J., Nair, V.K., Osterrieder, N.,
2007b. Horizontal transmission of Marek’s disease virus requires US2, the
UL13 protein kinase, and gC. J. Virol. 81 (19), 10575–10587.
Jarosinski, K.W., Osterrieder, N., Nair, V.K., Schat, K.A., 2005. Attenuation of
Marek’s disease virus by deletion of open reading frame RLORF4 but not
RLORF5a. J. Virol. 79 (18), 11647–11659.
Jarosinski, K.W., Tischer, B.K., Trapp, S., Osterrieder, N., 2006. Marek’s disease
virus: lytic replication, oncogenesis and control. Expert Rev. Vaccines 5 (6),
761–772.
Jones, D., Lee, L., Liu, J.L., Kung, H.J., Tillotson, J.K., 1992. Marek disease virus
encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is
highly expressed in lymphoblastoid tumors. Proc. Nat. Acad. Sci. U.S.A. 89 (9),
4042–4046.
Kattenhorn, L.M., Korbel, G.A., Kessler, B.M., Spooner, E., Ploegh, H.L., 2005. A
deubiquitinating enzyme encoded by HSV-1 belongs to a family of cysteine
proteases that is conserved across the family herpesviridae. Mol. Cell 19 (4),
547–557.
Kaufer, B.B., Smejkal, B., Osterrieder, N., 2010a. The Varicella–Zoster virus ORFS/L
(ORF0) gene is required for efﬁcient viral replication and contains an element
involved in DNA cleavage. J. Virol. 84 (22), 11661–11669.
Kaufer, B.B., Trapp, S., Jarosinski, K.W., Osterrieder, N., 2010b. Herpesvirus
telomerase RNA(vTR)-dependent lymphoma formation does not require inter-
action of vTR with telomerase reverse transcriptase (TERT). PLoS Pathog. 6 (8),
e1001073.
Kim, E.T., Oh, S.E., Lee, Y.O., Gibson, W., Ahn, J.H., 2009. Cleavage speciﬁcity of the
UL48 deubiquitinating protease activity of human cytomegalovirus and the
growth of an active-site mutant virus in cultured cells. J. Virol. 83 (23),
12046–12056.
Komander, D., Clague, M.J., Urbe, S., 2009. Breaking the chains: structure and
function of the deubiquitinases. Nat. Rev. Mol. Cell Biol. 10 (8), 550–563.Lupiani, B., Lee, L.F., Cui, X., Gimeno, I., Anderson, A., Morgan, R.W., Silva, R.F.,
Witter, R.L., Kung, H.J., Reddy, S.M., 2004. Marek’s disease virus-encoded Meq
gene is involved in transformation of lymphocytes but is dispensable for
replication. Proc. Nat. Acad. Sci. U.S.A. 101 (32), 11815–11820.
Michael, K., Bottcher, S., Klupp, B.G., Karger, A., Mettenleiter, T.C., 2006. Pseudora-
bies virus particles lacking tegument proteins pUL11 or pUL16 incorporate less
full-length pUL36 than wild-type virus, but speciﬁcally accumulate a pUL36
N-terminal fragment. J. Gen. Virol. 87 (Pt 12), 3503–3507.
Naviaux, R.K., Costanzi, E., Haas, M., Verma, I.M., 1996. The pCL vector system:
rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol.
70 (8), 5701–5705.
Nijman, S.M., Luna-Vargas, M.P., Velds, A., Brummelkamp, T.R., Dirac, A.M., Sixma,
T.K., Bernards, R., 2005. A genomic and functional inventory of deubiquitinat-
ing enzymes. Cell 123 (5), 773–786.
Osterrieder, N., Kamil, J.P., Schumacher, D., Tischer, B.K., Trapp, S., 2006. Marek’s
disease virus: from miasma to model. Nat. Rev. Microbiol. 4 (4), 283–294.
Petherbridge, L., Howes, K., Baigent, S.J., Sacco, M.A., Evans, S., Osterrieder, N., Nair,
V., 2003. Replication-competent bacterial artiﬁcial chromosomes of Marek’s
disease virus: novel tools for generation of molecularly deﬁned herpesvirus
vaccines. J. Virol. 77 (16), 8712–8718.
Pickart, C.M., Eddins, M.J., 2004. Ubiquitin: structures, functions, mechanisms.
Biochim. Biophys. Acta 1695 (1-3), 55–72.
Roberts, A.P., Abaitua, F., O’Hare, P., McNab, D., Rixon, F.J., Pasdeloup, D., 2009.
Differing roles of inner tegument proteins pUL36 and pUL37 during entry of
herpes simplex virus type 1. J. Virol. 83 (1), 105–116.
Sambrook, J., 2001. In: Russell, D.W., Cold Spring Harbor, L. (Eds.), Molecular
cloning: a laboratory manual/Joseph Sambrook, David W. Russell.. Cold Spring
Harbor Laboratory, Cold Spring Harbor, N.Y..
Schat, K.A., Calnek, B.W., Fabricant, J., 1981. Inﬂuence of the bursa of fabricius on
the pathogenesis of Marek’s disease. Infect. Immun. 31 (1), 199–207.
Schat KA, P.H., 1998. In: Swayne DE, G.J., Jackwood, M.W., Pearson, J.E., Reed, W.M.
(Eds.), A Laboratory Manual for the Isolation and Identiﬁcation of Avian
Pathogens. Am Assoc Avian Pathol, Kennett Square, PA, pp. 223–234.
Schlieker, C., Korbel, G.A., Kattenhorn, L.M., Ploegh, H.L., 2005. A deubiquitinating
activity is conserved in the large tegument protein of the herpesviridae.
J. Virol. 79 (24), 15582–15585.
Schlieker, C., Weihofen, W.A., Frijns, E., Kattenhorn, L.M., Gaudet, R., Ploegh, H.L.,
2007. Structure of a herpesvirus-encoded cysteine protease reveals a unique
class of deubiquitinating enzymes. Mol. Cell 25 (5), 677–687.
Tischer, B.K., Smith, G.A., Osterrieder, N., 2010. En passant mutagenesis: a two step
markerless red recombination system. Methods Mol. Biol. 634, 421–430.
Tischer, B.K., von Einem, J., Kaufer, B., Osterrieder, N., 2006. Two-step red-
mediated recombination for versatile high-efﬁciency markerless DNA manip-
ulation in Escherichia coli. Biotechniques 40 (2), 191–197.
Wang, J., Loveland, A.N., Kattenhorn, L.M., Ploegh, H.L., Gibson, W., 2006. High-
molecular-weight protein (pUL48) of human cytomegalovirus is a competent
deubiquitinating protease: mutant viruses altered in its active-site cysteine or
histidine are viable. J. Virol. 80 (12), 6003–6012.
Whitehurst, C.B., Ning, S., Bentz, G.L., Dufour, F., Gershburg, E., Shackelford, J.,
Langelier, Y., Pagano, J.S., 2009. The Epstein–Barr virus (EBV) deubiquitinating
enzyme BPLF1 reduces EBV ribonucleotide reductase activity. J. Virol. 83 (9),
4345–4353.
Whitehurst, C.B., Vaziri, C., Shackelford, J., Pagano, J.S., 2012. Epstein–Barr virus
BPLF1 deubiquitinates PCNA and attenuates polymerase eta recruitment to
DNA damage sites. J. Virol. 86 (15), 8097–8106.
